ARISTI LIMITED
Company number 06504641 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: ARISTI LIMITED
1. Financial Health Score: C+
Explanation: While the patient is not in critical condition, recent test results show concerning symptoms of distress. The business has a strong heartbeat (positive cash balances) and is actively investing in its operational capacity, but it has suffered a significant bleed in retained earnings over the latest financial year. The rapid accumulation of short-term liabilities to fund long-term assets has caused a concerning contraction in working capital, leaving the business with a weakened immune system against future economic shocks.
2. Key Vital Signs
- Blood Pressure (Liquidity & Working Capital): The current ratio (Current Assets vs. Current Liabilities) has dropped from a healthy 1.69 in 2024 to 1.26 in 2025. While still above 1.0, this narrowing of the arteries indicates that short-term obligations are piling up faster than liquid assets. Net current assets fell by nearly 50%, from £277,569 to £143,076.
- Weight Loss (Retained Earnings & Net Assets): The business has experienced noticeable weight loss. Shareholders' funds dropped by 43%, falling from £301,672 to £172,063. Retained earnings took a hit of approximately £129,609 (£293,172 down to £163,563), suggesting a significant loss was incurred during the 2025 financial year, or a substantial dividend was extracted—either way, the equity cushion has thinned.
- Pulse (Cash Position): The pulse remains steady and strong. Cash at bank increased from £88,924 to £121,069. This indicates the business is still generating or holding liquidity, which keeps it out of immediate cardiac arrest.
- Cholesterol (Debt Levels): Total liabilities have surged by roughly 35%, from £398,700 to £538,394. Short-term bank loans/overdrafts spiked from £26,003 to £86,839, and new long-term finance lease obligations (£28,555) have been introduced. Crucially, these bank loans are secured against the company's assets, adding pressure to the business's vital organs.
3. Diagnosis
The financial data reveals a business experiencing a working capital squeeze due to aggressive capital investment, likely compounded by a period of unprofitability.
Aristi Limited has significantly increased its tangible assets, particularly motor vehicles and equipment (rising from £31,714 to £72,221 in net book value). The addition of £66,600 in new equipment and vehicles suggests the company is investing heavily in its operational infrastructure. However, the diagnosis is clouded by how this investment was funded: the business took on substantial short-term debt and overdrafts to finance what are long-term assets. In medical terms, this is like using a short-term stimulant (short-term debt) to build long-term stamina (fixed assets)—it creates a maturity mismatch that strains the circulatory system (working capital).
Furthermore, the drop in trade debtors (from £371,208 to £277,651) alongside the drop in retained earnings suggests one of two scenarios: either the business experienced a sharp decline in revenue/recognition of income, or it collected older debts but failed to replace them with new billable work at the same margin. The increase in accrued income and deferred revenue (£152,158 vs £95,290) also indicates a shift in how cash is flowing through the business, with more obligations waiting in the reception room.
4. Recommendations
To restore the business to full financial fitness, the following treatment plan is recommended:
- Diet and Exercise (Debt Restructuring): The most urgent treatment is addressing the maturity mismatch. The £86,839 in short-term bank loans/overdrafts used to fund the business should ideally be refinanced into a long-term facility. This will relieve the immediate pressure on working capital and stop the bleeding of cash reserves when these notes come due.
- Vitals Monitoring (Cash Flow Management): With 30 employees and high social security/tax obligations (£168,324), the monthly cash "burn rate" is significant. Management must closely monitor weekly cash flow forecasts to ensure the £121,069 cash reserve isn't rapidly depleted by the rising current liabilities.
- Physical Therapy (Asset Utilization): The heavy investment in motor vehicles and equipment must now generate a return. Management should track the revenue-per-asset to ensure these new additions are pulling their weight and not just sitting idle in the garage.
- Root Cause Analysis (Profitability): An internal audit into the £129,609 drop in retained earnings is critical. If this was a trading loss, the underlying operational costs must be trimmed. If it was a dividend payout to the parent company (Cipher Opco Limited), the board must ensure the business retains enough nutrients to sustain its own growth.